[Diagnostic and therapeutic approach of intraabdominal candidiasis].
Invasive fungal disease is associated to a high mortality rate on critical ill patients. In the last decades an important epidemiological shift has been described. Early diagnosis and treatment are related with a better prognosis. The key factors lie in a set of predictive scores that allow to identify patients that will benefit of early treatment, as well as using diagnosis techniques that are culture independent. New diagnosis approximations are being developed with promising results: in situ hybridisation using PNA-FISH probes, MALDI-TOF MS and rapid nucleic acids detection assays. The use of echinocandin is recommended as antifungal therapy on critical ill patients with candida peritonitis.
A
A
Montero
F
F
Gilsanz
Emilio Maseda, Servicio de Anestesia y Reanimación, Hospital Universitario La Paz, Paseo de la Castellana 261; 28046, Madrid, Spain. emilio.maseda@gmail.com.
E
E
Maseda
D000935:Antifungal Agents / Q000627:therapeutic use*; D002177:Candidiasis / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology; D058365:Candidiasis, Invasive / Q000188:drug therapy; D006801:Humans; D059413:Intraabdominal Infections / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology
D000935:Antifungal Agents